Evidence-based and heuristic approaches for customization of care in cardiometabolic syndrome after spinal cord injury

Journal of Spinal Cord Medicine

Volumn 35, Issue 5, 2012, Pages 278-292

  Nash, Mark S ^a   Cowan, Rachel E ^a   Kressler, Jochen ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Atherogenesis; Drug therapy; Exercise therapy; Metabolic cardiovascular syndrome; Nutrition therapy; Paraplegia; Spinal cord injuries; Tetraplegia

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA TOCOPHEROL; ASCORBIC ACID; ATORVASTATIN; BIOTIN; CALCIUM; CHLORIDE; CHROMIUM; COLESEVELAM; COLESTIPOL; COLESTYRAMINE; COPPER; DIPEPTIDYL PEPTIDASE IV INHIBITOR; EZETIMIBE; FENOFIBRATE; GEMFIBROZIL; MEGLITINIDE; METFORMIN; MEVINOLIN; NICOTINIC ACID; PANTOTHENIC ACID; PRAVASTATIN; RETINOL; ROSUVASTATIN; SIMVASTATIN; SULFONYLUREA; TETRAHYDROLIPSTATIN; VITAMIN D; VITAMIN K GROUP;

ALCOHOL CONSUMPTION; CALORIC INTAKE; CARBOHYDRATE INTAKE; CARDIOMETABOLIC SYNDROME; CHOLESTEROL INTAKE; CONFERENCE PAPER; DIET SUPPLEMENTATION; DIET THERAPY; DYSGLYCEMIA; DYSLIPIDEMIA; EVIDENCE BASED MEDICINE; EXERCISE INTENSITY; GLUCOSE HOMEOSTASIS; GOOD CLINICAL PRACTICE; HEALTH HAZARD; HUMAN; KINESIOTHERAPY; LIFESTYLE MODIFICATION; METABOLIC DISORDER; PATIENT CARE; PERSONALIZED MEDICINE; PHYSICAL ACTIVITY; PRIMARY PREVENTION; RISK ASSESSMENT; RISK FACTOR; SPINAL CORD INJURY; VITAMIN SUPPLEMENTATION;

CARDIOVASCULAR DISEASES; EVIDENCE-BASED MEDICINE; EXERCISE THERAPY; HUMANS; SPINAL CORD INJURIES;

EID: 84867316592     PISSN: 10790268     EISSN: 20457723     Source Type: Journal    
DOI: 10.1179/2045772312Y.0000000034     Document Type: Conference Paper

References (126)

1. Nash MS, Mendez AJ. A guideline-driven assessment of need for cardiovascular disease risk intervention in persons with chronic paraplegia. Arch Phys Med Rehabil 2007;88(6):751-7. (Pubitemid 46805153)
2. Bauman WA, Spungen AM. Coronary heart disease in individuals with spinal cord injury: assessment of risk factors. Spinal Cord 2008;46(7):466-76. (Pubitemid 351948237)
3. Wahman K, Nash MS, Westgren N, Lewis JE, Seiger A, Levi R. Cardiovascular disease risk factors in persons with paraplegia: the Stockholm spinal cord injury study. J Rehabil Med 2010;42(3):272-8.
4. Groah SL, Nash MS, Ward EA, Libin A, Mendez AJ, Burns P, et al. Cardiometabolic risk in community-dwelling persons with chronic spinal cord injury. J Cardiopulmonary Rehabil Prevent. 2011;31(2):73-80.
5. Govindarajan G, Whaley-Connell A, Mugo M, Stump C, Sowers JR. The cardiometabolic syndrome as a cardiovascular risk factor. Am J Med Sci 2005;330(6):311-8. (Pubitemid 41831902)
6. Third Report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 2002;106(25):3143-421.
7. Grassi G, Seravalle G, Quarti-Trevano F, Dell'Oro R, Bombelli M, Mancia G. Metabolic syndrome and cardiometabolic risk: an update. Blood Press 2009;18(1-2):7-16.
8. Bauman WA, Spungen AM. Metabolic changes in persons after spinal cord injury. Phys Med Rehabil Clin N Am 2000;11(1):109-40. (Pubitemid 30075583)
9. Cowan RE, Nash MS. Cardiovascular disease, SCI and exercise: unique risks and focused countermeasures. Disabil Rehabil 2010;32(26):2228-36.
10. Ashraf SG, David RG, Jr. Prevalence of obesity after spinal cord injury. Top Spinal Cord Inj Rehabil 2007;12(4):1-7.
11. Buchholz AC, Bugaresti JM. A review of body mass index and waist circumference as markers of obesity and coronary heart disease risk in persons with chronic spinal cord injury. Spinal Cord 2005;43(9):513-8. (Pubitemid 41309041)
12. Spungen AM, Adkins RH, Stewart CA, et al. Factors influencing body composition in persons with spinal cord injury: a cross-sectional study. J Appl Physiol 2003;95(6):2398-407. (Pubitemid 37444985)
13. Duckworth WC, Solomon SS, Jallepalli P, Heckemeyer C, Finnern J, Powers A. Glucose intolerance due to insulin resistance in patients with spinal cord injuries. Diabetes 1980;29(11):906-10. (Pubitemid 11022288)
14. Bauman WA, Spungen AM. Disorders of carbohydrate and lipid metabolism in veterans with paraplegia or quadriplegia: a model of premature aging. Metabolism 1994;43(6):749-56. (Pubitemid 24181204)
15. Lee MY, Myers J, Hayes A, Madan S, Froelicher VF, Perkash I, et al. C-reactive protein, metabolic syndrome, and insulin resistance in individuals with spinal cord injury. J Spinal Cord Med 2005;28(1):20-5. (Pubitemid 43108144)
16. Bauman WA, Spungen AM. Carbohydrate and lipid metabolism in chronic spinal cord injury. J Spinal Cord Med 2001;24(4):266-77. (Pubitemid 37484217)
17. Myers J, Lee M, Kiratli J. Cardiovascular disease in spinal cord injury: an overview of prevalence, risk, evaluation, and management. Am J Phys Med Rehabil 2007;86(2):142-52. (Pubitemid 46148688)
18. Nash MS, DeGroot J, Martinez-Arizala A, Mendez AJ. Evidence for an exaggerated postprandial lipemia in chronic paraplegia. J Spinal Cord Med 2005;28(4):320-5. (Pubitemid 43108123)
19. Emmons RR, Garber CE, Cirnigliaro CM, Moyer JM, Kirshblum SC, Galea MD, et al. The influence of visceral fat on the postprandial lipemic response in men with paraplegia. J Am Coll Nutr 2010;29(5):476-81.
20. Nash MS. Central nervous system: spinal cord injury. In: Frontera WR, Dawson DM, Slovik Dm E, (eds.) Exercise in rehabilitation medicine. Champaign, IL: Human Kinetic Publishers; 2006. p. 191-205.
21. Nash MS. Cardiovascular fitness after spinal cord injuries. In: Lin V, (ed.) Spinal cord medicine. New York, NY: Demos Medical Publications; 2002. p. 637-46.
22. Frost F, Roach MJ, Kushner I, Schreiber P. Inflammatory C-reactive protein and cytokine levels in asymptomatic people with chronic spinal cord injury. Arch Phys Med Rehabil 2005;86(2):312-7. (Pubitemid 40215296)
23. Manns PJ, McCubbin JA, Williams DP. Fitness, inflammation, and the metabolic syndrome in men with paraplegia. Arch Phys Med Rehabil 2005;86(6):1176-81. (Pubitemid 40797772)
24. Liang H, Mojtahedi MC, Chen D, Braunschweig CL. Elevated c-reactive protein associated with decreased high-density lipoprotein cholesterol in men with spinal cord injury. Arch Phys Med Rehabil 2008;89(1):36-41. (Pubitemid 350298997)
25. Vasudevan AR, Ballantyne CM. Cardiometabolic risk assessment: an approach to the prevention of cardiovascular disease and diabetes mellitus. Clin Cornerstone 2005;7(2-3):7-16. (Pubitemid 43205318)
26. Ginsberg HN, Stalenhoef AF. The metabolic syndrome: targeting dyslipidaemia to reduce coronary risk. J Cardiovasc Risk 2003;10(2):121-8.
27. Groah SL, Libin A, Lauderdale M, Kroll T, DeJong G, Hsieh J. Beyond the evidence-based practice paradigm to achieve best practice in rehabilitation medicine: a clinical review. PMR 2009;1(10):941-50.
28. McKenney JM. Update on the National Cholesterol Education Program Adult Treatment Panel III guidelines: getting to goal. Pharmacotherapy 2003;23(9 Pt 2):26S-33S. (Pubitemid 37158771)
29. Feasel S, Groah S. The impact of diet on cardiovascular disease risk in individuals with spinal cord injury. Top Spinal Cord Inj Rehabil 2009;14(3):56-68.
30. Lake A, Townshend T. Obesogenic environments: exploring the built and food environments. J R Soc Promot Health 2006;126(6):262-7. (Pubitemid 44614112)
31. Groah SL, Nash MS, Ljungberg IH, Libin A, Hamm LF, Ward E, et al. Nutrient intake and body habitus after spinal cord injury: an analysis by sex and level of injury. J Spinal Cord Med 2009;32(1):25-33.
32. U.S. Department of Agriculture and U.S. Department of Health and Human Services. Dietary guidelines for Americans. 7th ed. Washington, DC: Government Printing Office; 2010. p. 112.
33. Walters JL, Buchholz AC, Martin Ginis KA. Evidence of dietary inadequacy in adults with chronic spinal cord injury. Spinal Cord 2009;47(4):318-22.
34. Perret C, Stoffel-Kurt N. Comparison of nutritional intake between individuals with acute and chronic spinal cord injury. J Spinal Cord Med 2011;34(6):569-75.
35. Edwards LA, Bugaresti JM, Buchholz AC. Visceral adipose tissue and the ratio of visceral to subcutaneous adipose tissue are greater in adults with than in those without spinal cord injury, despite matching waist circumferences. Am J Clin Nutr 2008;87(3):600-7. (Pubitemid 351364540)
36. Tomey KM, Chen DM, Wang X, Braunschweig CL. Dietary intake and nutritional status of urban community-dwelling men with paraplegia. Arch Phys Med Rehabil 2005;86(4):664-71. (Pubitemid 40487830)
37. Levine AM, Nash MS, Green BA, Shea JD, Aronica MJ. An examination of dietary intakes and nutritional status of chronic healthy spinal cord injured individuals. Paraplegia 1992;30(12):880-9. (Pubitemid 23036526)
38. Aquilani R, Boschi F, Contardi A, Pistarini C, Achilli MP, Fizzotti G, et al. Energy expenditure and nutritional adequacy of rehabilitation paraplegics with asymptomatic bacteriuria and pressure sores. Spinal Cord 2001;39(8):437-41. (Pubitemid 32769805)
39. Lee BY, Agarwal N, Corcoran L, Thoden WR, Del Guercio LR. Assessment of nutritional and metabolic status of paraplegics. J Rehabil Res Dev 1985;22(3):11-7. (Pubitemid 16056331)
40. Sabour H, Javidan AN, Vafa MR, Shidfar F, Nazari M, Saberi H, et al. Calorie and macronutrients intake in people with spinal cord injuries: an analysis by sex and injury-related variables. Nutrition 2012;28(2):143-7.
41. Peiffer SC, Blust P, Leyson JF. Nutritional assessment of the spinal cord injured patient. J Am Diet Assoc 1981;78(5):501-5.
42. Barboriak JJ, Rooney CB, El Ghatit AZ, Spuda K, Anderson AJ. Nutrition in spinal cord injury patients. J Am Paraplegia Soc 1983;6(2):32-6.
43. Aghaeishahsavari M, Noroozianavval M, Veisi P, Parizad R, Samadikhah J. Cardiovascular disease risk factors in patients with confirmed cardiovascular disease. Saudi Med J 2006;27(9):1358-61. (Pubitemid 44420370)
44. Moussavi RM, Ribas-Cardus F, Rintala DH, Rodriguez GP. Dietary and serum lipids in individuals with spinal cord injury living in the community. J Rehabil Res Dev 2001;38(2):225-33. (Pubitemid 34118855)
45. Zlotolow SP, Levy E, Bauman WA. The serum lipoprotein profile in veterans with paraplegia: the relationship to nutritional factors and body mass index. J Am Paraplegia Soc 1992;15(3):158-62.
46. Hooper L, Summerbell CD, Thompson R, Sills D, Roberts FG, Moore HJ, et al. Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database Syst Rev 2012;5:CD002137.
47. Schrauwen P, Westerterp KR. The role of high-fat diets and physical activity in the regulation of body weight. Br J Nutr 2000;84(4):417-27.
48. Knight KH, Buchholz AC, Martin Ginis KA, Goy RE. Leisure-time physical activity and diet quality are not associated in people with chronic spinal cord injury. Spinal Cord 2011;49(3):381-5.
49. Battista P, Di Primio R, Di Luzio A, Nubile G, Di Tano G. Correlations between dietetic fiber and serum levels of total cholesterol and HDL-cholesterol. Boll Soc Ital Biol Sper 1983;59(1):83-6.
50. Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr 1999;69(1):30-42. (Pubitemid 29031248)
51. Mietus-Snyder ML, Shigenaga MK, Suh JH, Shenvi SV, Lal A, McHugh T, et al. A nutrient-dense, high-fiber, fruit-based supplement bar increases HDL cholesterol, particularly large HDL, lowers homocysteine, and raises glutathione in a 2-wk trial. FASEB J 2012;26(8):3515-27. Epub 2012 May 1.
52. Reyna-Villasmil N, Bermudez-Pirela V, Mengual-Moreno E, Arias N, Cano-Ponce C, Leal-Gonzalez E, et al. Oat-derived beta-glucan significantly improves HDLC and diminishes LDLC and non-HDL cholesterol in overweight individuals with mild hypercholesterolemia. Am J Ther 2007;14(2):203-12. (Pubitemid 46597661)
53. Cameron KJ, Nyulasi IB, Collier GR, Brown DJ. Assessment of the effect of increased dietary fibre intake on bowel function in patients with spinal cord injury. Spinal Cord 1996;34(5):277-83. (Pubitemid 26188559)
54. Krassioukov A, Eng JJ, Claxton G, Sakakibara BM, Shum S. Neurogenic bowel management after spinal cord injury: a systematic review of the evidence. Spinal Cord 2010;48(10):718-33.
55. Laven GT, Huang CT, DeVivo MJ, Stover SL, Kuhlemeier KV, Fine PR. Nutritional status during the acute stage of spinal cord injury. Arch Phys Med Rehabil 1989;70(4):277-82. (Pubitemid 19110568)
56. Moussavi RM, Garza HM, Eisele SG, Rodriguez G, Rintala DH. Serum levels of vitamins A, C, and E in persons with chronic spinal cord injury living in the community. Arch Phys Med Rehabil 2003;84(7):1061-7. (Pubitemid 36835136)
57. Berger D. Dietary management of the paraplegic patient. Can Serv Med J 1954;10(1):65-70.
58. Khandare AL, Shankar NH, Kalyanasundaram S, Rao GS. Effect of calcium deficiency induced by fluoride intoxication on lipid metabolism in rabbits. Fluoride 2007;40(3):184-9. (Pubitemid 47612347)
59. Chaudhary DP, Sharma R, Bansal DD. Implications of magnesium deficiency in type 2 diabetes: a review. Biol Trace Elem Res 2010;134(2):119-29.
60. Olson ML, Maalouf NM, Oden JD, White PC, Hutchison MR. Vitamin D deficiency in obese children and its relationship to glucose homeostasis. J Clin Endocrinol Metab 2012;97(1):279-85.
61. Fattoretti P, Bertoni-Freddari C, Casoli T, Di Stefano G, Solazzi M, Giorgetti B. Decreased expression of glucose transport protein (Glut3) in aging and vitamin E deficiency. Ann N Y Acad Sci 2002;973:293-6. (Pubitemid 36125024)
62. Frikke-Schmidt H, Lykkesfeldt J. Role of marginal vitamin C deficiency in atherogenesis: in vivo models and clinical studies. Basic Clin Pharmacol Toxicol 2009;104(6):419-33.
63. Grungreiff K, Reinhold D. Liver cirrhosis and 'liver' diabetes mellitus are linked by zinc deficiency. Med Hypotheses 2005;64(2):316-7. (Pubitemid 40022671)
64. Kaya A, Altiner A, Ozpinar A. Effect of copper deficiency on blood lipid profile and haematological parameters in broilers. J Vet Med A Physiol Pathol Clin Med 2006;53(8):399-404. (Pubitemid 44393585)
65. Larrieta E, Vega-Monroy ML, Vital P, Aguilera A, German MS, Hafidi ME, et al. Effects of biotin deficiency on pancreatic islet morphology, insulin sensitivity and glucose homeostasis. J Nutr Biochem 2012;23(4):392-99.
66. Matthews KA, Rhoten WB, Driscoll HK, Chertow BS. Vitamin A deficiency impairs fetal islet development and causes subsequent glucose intolerance in adult rats. J Nutr 2004;134(8):1958-63. (Pubitemid 39031324)
67. McRae MP. Vitamin C supplementation lowers serum low-density lipoprotein cholesterol and triglycerides: a meta-analysis of 13 randomized controlled trials. J Chiropr Med 2008;7(2):48-58.
68. Nielsen FH, Milne DB, Klevay LM, Gallagher S, Johnson L. Dietary magnesium deficiency induces heart rhythm changes, impairs glucose tolerance, and decreases serum cholesterol in post menopausal women. J Am Coll Nutr 2007;26(2):121-32. (Pubitemid 46911255)
69. Reiterer G, MacDonald R, Browning JD, Morrow J, Matveev SV, Daugherty A, et al. Zinc deficiency increases plasma lipids and atherosclerotic markers in LDL-receptor-deficient mice. J Nutr 2005;135(9):2114-8. (Pubitemid 41298374)
70. Rowe JW, Tobin JD, Rosa RM, Andres R. Effect of experimental potassium deficiency on glucose and insulin metabolism. Metabolism. 1980;29(6):498-502. (Pubitemid 10123237)
71. Yoshida M, Jacques PF, Meigs JB, Saltzman E, Shea MK, Gundberg C, et al. Effect of vitamin K supplementation on insulin resistance in older men and women. Diabetes Care 2008;31(11):2092-6.
72. Langer RD, Criqui MH, Reed DM. Lipoproteins and blood pressure as biological pathways for effect of moderate alcohol consumption on coronary heart disease. Circulation 1992;85(3):910-15.
73. Corrao G, Rubbiati L, Bagnardi V, Zambon A, Poikolainen K. Alcohol and coronary heart disease: a meta-analysis. Addiction 2000;95(10):1505-23.
74. Wakabayashi I. Increased body mass index modifies associations between alcohol intake and blood cholesterol profile. Eur J Clin Invest 2012;42(2):179-85.
75. Saunders LL, Krause JS. Psychological factors affecting alcohol use after spinal cord injury. Spinal Cord 2011;49(5):637-42.
76. Tate DG, Forchheimer MB, Krause JS, Meade MA, Bombardier CH. Patterns of alcohol and substance use and abuse in persons with spinal cord injury: risk factors and correlates. Arch Phys Med Rehabil 2004;85(11):1837-47. (Pubitemid 39441142)
77. Bombardier CH, Rimmele CT. Alcohol use and readiness to change after spinal cord injury. Arch Phys Med Rehabil 1998;79(9):1110-15. (Pubitemid 28419321)
78. Phillips E, Gater DR. A practical Approach for the nutritional management of obesity in spinal cord injury. Top Spinal Cord Inj Rehabil 2007;12(4):64-75.
79. Szlachcic Y, Adkins RH, Adal T, Yee F, Bauman W, Waters RL. The effect of dietary intervention on lipid profiles in individuals with spinal cord injury. J Spinal Cord Med 2001;24(1):26-9. (Pubitemid 37484224)
80. Chen Y, Henson S, Jackson AB, Richards JS. Obesity intervention in persons with spinal cord injury. Spinal Cord 2006;44(2):82-91. (Pubitemid 43190351)
81. Liusuwan RA,Widman LM, Abresch RT, Styne DM, McDonald CM. Body composition and resting energy expenditure in patients aged 11 to 21 years with spinal cord dysfunction compared to controls: comparisons and relationships among the groups. J Spinal Cord Med 2007;30(Suppl. 1):105-11.
82. Zemper ED, Tate DG, Roller S, Forchheimer M, Chiodo A, Nelson VS, et al. Assessment of a holistic wellness program for persons with spinal cord injury. Am J Phys Med Rehabil 2003;82(12):957-68. Quiz 969-71.
83. Emon ST, Irban AG, Bozkurt SU, Akakin D, Konya D, Ozgen S. Effects of parenteral nutritional support with fish-oil emulsion on spinal cord recovery in rats with traumatic spinal cord injury. Turk Neurosurg 2011;21(2):197-202.
84. Huang WL, King VR, Curran OE, Dyall SC, Ward RE, Lal N, et al. A combination of intravenous and dietary docosahexaenoic acid significantly improves outcome after spinal cord injury. Brain 2007;130(Pt 11):3004-19. (Pubitemid 350033967)
85. Javierre C, Vidal J, Segura R, Medina J, Garrido E. Continual supplementation with n-3 fatty acids does not modify plasma lipid profile in spinal cord injury patients. Spinal Cord 2005;43(9):527-30. (Pubitemid 41309043)
86. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002;106(21):2747-57. (Pubitemid 35364932)
87. Harris WS. n-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 1997;65(5 Suppl.):1645S-54S. (Pubitemid 27187958)
88. Kris-Etherton PM, Harris WS, Appel LJ. Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association. Arterioscler Thromb Vasc Biol 2003;23(2):151-2. (Pubitemid 36231919)
89. Tasiemski T, Bergstrom E, Savic G, Gardner BP. Sports, recreation and employment following spinal cord injury - a pilot study. Spinal Cord 2000;38(3):173-84. (Pubitemid 30171058)
90. Ginis KA, Arbour-Nicitopoulos KP, Latimer AE, Buchholz AC, Bray SR, Craven BC, et al. Leisure time physical activity in a population-based sample of people with spinal cord injury part II: activity types, intensities, and durations. Arch Phys Med Rehabil 2010;91(5):729-33.
91. Ginis KA, Latimer AE, Arbour-Nicitopoulos KP, Buchholz AC, Bray SR, Craven BC, et al. Leisure time physical activity in a population-based sample of people with spinal cord injury part I: demographic and injury-related correlates. Arch Phys Med Rehabil 2010;91(5):722-8.
92. Centers for Disease Control and Prevention. National Center for Health Statistics. Health Indicators Warehouse. 2009-2010. Available from: http://healthindicators.gov/Indicators/Leisure-time-physical-activity-none- percent-1313 / National-0/Profile/Data.
93. El-Sayed MS, Younesian A. Lipid profiles are influenced by arm cranking exercise and training in individuals with spinal cord injury. Spinal Cord 2005;43(5):299-305. (Pubitemid 40704992)
94. Nash MS, Jacobs PL, Mendez AJ, Goldberg RB. Circuit resistance training improves the atherogenic lipid profile in persons with chronic paraplegia. J Spinal Cord Med 2001;24(1):2-9. (Pubitemid 37484221)
95. Hooker SP, Wells CL. Effects of low- and moderate-intensity training in spinal cord-injured persons. Med Sci Sports Exerc 1989;21(1):18-22. (Pubitemid 19062842)
96. de Groot PC, Hjeltnes N, Heijboer AC, Stal W, Birkeland K. Effect of training intensity on physical capacity, lipid profile and insulin sensitivity in early rehabilitation of spinal cord injured individuals. Spinal Cord 2003;41(12):673-9. (Pubitemid 37533129)
97. Dallmeijer AJ, Hopman MT, van der Woude LH. Lipid, lipoprotein, and apolipoprotein profiles in active and sedentary men with tetraplegia. Arch Phys Med Rehabil 1997;78(11):1173-6. (Pubitemid 27494630)
98. Janssen TW, van Oers CA, van Kamp GJ, TenVoorde BJ, van der Woude LH, Hollander AP. Coronary heart disease risk indicators, aerobic power, and physical activity in men with spinal cord injuries. Arch Phys Med Rehabil 1997;78(7):697-705. (Pubitemid 27295113)
99. Buchholz AC, Martin Ginis KA, Bray SR, Craven BC, Hicks AL, Hayes KC, et al. Greater daily leisure time physical activity is associated with lower chronic disease risk in adults with spinal cord injury. Appl Physiol Nutr Metab 2009;34(4):640-7.
100. de Groot S, Dallmeijer AJ, Post MW, Angenot EL, van den Berg-Emons RJ, van der Woude LH. Prospective analysis of lipid profiles in persons with a spinal cord injury during and 1 year after inpatient rehabilitation. Arch Phys Med Rehabil 2008;89(3):531-7. (Pubitemid 351273183)
101. Carlson KF, Wilt TJ, Taylor BC, Goldish GD, Niewoehner CB, Shamliyan TA, et al. Effect of exercise on disorders of carbohydrate and lipid metabolism in adults with traumatic spinal cord injury: systematic review of the evidence. J Spinal Cord Med 2009;32(4):361-78.
102. Ginis KA, Hicks AL, Latimer AE, Warburton DE, Bourne C, Ditor DS, et al. The development of evidence-informed physical activity guidelines for adults with spinal cord injury. Spinal Cord 2011;49(11):1088-96.
103. U.S. Department of Health and Human Services. Physical Activity Guidelines for Americans. Centers for Disease Control and Prevention, National Center for Health Statistics. 2008. Available from: www.hhs.gov.
104. Canadian Society for Exercise Physiology, Canadian Physical Activity Guidelines, 2012 Scientific Statements. Available from: www.csep.ca/guidelines.
105. Manns PJ, Dunstan DW, Owen N, Healy GN. Addressing the nonexercise part of the activity continuum: a more realistic and achievable approach to activity programming for adults with mobility disability? Phys Ther 2012;92(4):614-25.
106. Warburton DE, Gledhill N, Jamnik VK, Bredin SS, McKenzie DC, Stone J, et al. Evidence-based risk assessment and recommendations for physical activity clearance: Consensus Document 2011 (1) (1) This paper is one of a selection of papers published in this Special Issue, entitled Evidence-based risk assessment and recommendations for physical activity clearance, and has undergone the Journal's usual peer review process. Appl Physiol Nutr Metab 2011;36(Suppl. 1):S266-98.
107. Arbour-Nicitopoulos KP, Ginis KA. Universal accessibility of 'accessible' fitness and recreational facilities for persons with mobility disabilities. Adapt Phys Activ Q 2011;28(1):1-15.
108. Nash MS. Exercise as a health-promoting activity following spinal cord injury. J Neurol Phys Ther 2005;29(2):87-103, 106.
109. Weltman A, Matter S, Stamford BA. Caloric restriction and/or mild exercise: effects on serum lipids and body composition. Am J Clin Nutri 1980;33(5):1002-9. (Pubitemid 10040632)
110. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J 2001;22(7):554-72.
111. Kopelman P, Groot Gde H, Rissanen A, Rossner S, Toubro S, Palmer R, et al. Weight loss, HbA1c reduction, and tolerability of cetilistat in a randomized, placebo-controlled phase 2 trial in obese diabetics: comparison with orlistat (Xenical). Obesity 2010;18(1):108-15.
112. Goldberg R. Guideline-driven Intervention on SCI-Associated dyslipididemia, metabolic syndrome, and glucose intolerance using pharmacological agents. Top Spinal Cord Inj Rehabil 2009;14(3):46-57.
113. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, et al. Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2009;52(1):17-30.
114. Bolen S, Feldman L, Vassy J, Wilson L, Yeh HC, Marinopoulos S, et al. Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus. Ann Intern Med 2007;147(6):386-99. (Pubitemid 351664540)
115. Goldberg RB, Sabharwal AK. Fish oil in the treatment of dyslipidemia. Curr Opin Endocrinol Diabetes Obes 2008;15(2):167-74. (Pubitemid 351651730)
116. Khachatryan V, Sirunyan AM, Tumasyan A, Adam W, Bergauer T, Dragicevic M, et al. Search for quark compositeness with the dijet centrality ratio in pp collisions at radicals = 7 TeV. Phys Rev Lett 2010;105(2):022002. Epub 2010 Jul 6.
117. Dyson-Hudson T, Nash MS. Guideline-driven assessment of cardiovascular disease and related risks after spinal cord injury. Top Spinal Cord Inj Rehabil 2009;14:32-45.
118. Farmer JA. Statins and myotoxicity. Curr Atheroscler Rep 2003;5(2):96-100. (Pubitemid 38898858)
119. Klopstock T. Drug-induced myopathies. Curr Opin Neurol 2008;21(5):590-5.
120. Nash MS, Goldberg RB. Higher starting doses of atorvastatin may reduce LDL-cholesterol levels more than lower doses. Commentary. Evid Based Cardiovasc Med 2005;9(2):98-101.
121. Marcoff L, Thompson PD. The role of coenzyme Q10 in statin-associated myopathy: a systematic review. J Am Coll Cardiol 2007;49(23):2231-7. (Pubitemid 46856819)
122. Goldberg AC. Clinical trial experience with extended-release niacin (Niaspan): dose-escalation study. Am J Cardiol 1998;82(12A):35U-8U. (Pubitemid 29047614)
123. Knopp RH, Ginsberg J, Albers JJ, Hoff C, Ogilvie JT, Warnick GR, et al. Contrasting effects of unmodified and time-release forms of niacin on lipoproteins in hyperlipidemic subjects: clues to mechanism of action of niacin. Metabolism 1985;34(7):642-50. (Pubitemid 15036921)
124. Morgan JM, Capuzzi DM, Guyton JR. A new extended-release niacin (Niaspan): efficacy, tolerability, and safety in hypercholesterolemic patients. Am J Cardiol 1998;82(12A):29U-34U. (Pubitemid 29047613)
125. Brenes G, Dearwater S, Shapera R, LaPorte RE, Collins E. High density lipoprotein cholesterol concentrations in physically active and sedentary spinal cord injured patients. Arch Phys Med Rehabil 1986;67(7):445-50. (Pubitemid 16067702)
126. Nash MS, Lewis JE, Dyson-Hudson TA, Szlachcic Y, Yee F, Mendez AJ, et al. Safety, tolerance, and efficacy of extended-release niacin monotherapy for treating dyslipidemia risks in persons with chronic tetraplegia: a randomized multicenter controlled trial. Arch Phys Med Rehabil 2011;92(3):399-410.